These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis. Martini N; Rizzo S; Sarais C; Cipriani A BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442 [TBL] [Abstract][Full Text] [Related]
26. [Diagnostics of cardiac amyloidosis]. Meier C; Yilmaz A Inn Med (Heidelb); 2023 Sep; 64(9):830-841. PubMed ID: 37553542 [TBL] [Abstract][Full Text] [Related]
27. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171 [TBL] [Abstract][Full Text] [Related]
28. Step-by-step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis. Moriyama H; Kitakata H; Endo J; Ikura H; Sano M; Tasaki M; Sakai S; Ueda M; Fukuda K ESC Heart Fail; 2022 Apr; 9(2):1474-1477. PubMed ID: 35060353 [TBL] [Abstract][Full Text] [Related]
29. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis. Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596 [TBL] [Abstract][Full Text] [Related]
30. New quantitative indices of cardiac amyloidosis with Matsuda N; Otsuka H; Otani T; Azane S; Kunikane Y; Otomi Y; Ueki Y; Kubota M; Amano M; Yagi S; Sata M; Harada M Jpn J Radiol; 2023 Apr; 41(4):428-436. PubMed ID: 36449252 [TBL] [Abstract][Full Text] [Related]
31. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993 [TBL] [Abstract][Full Text] [Related]
32. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. Gallini C; Tutino F; Martone R; Ciaccio A; Costanzo EN; Taborchi G; Morini S; Bartolini S; Farsetti S; Di Mario C; Perfetto F; Cappelli F J Nucl Cardiol; 2021 Feb; 28(1):90-99. PubMed ID: 30767162 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782 [TBL] [Abstract][Full Text] [Related]
38. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]